Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics

[1]  N. Kutaiba,et al.  Sarcopenia measurements and clinical outcomes in Crohn's disease surgical patients , 2022, ANZ journal of surgery.

[2]  A. Ponsiglione,et al.  Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn’s Disease Patients Undergoing Multidetector CT-Enterography , 2022, Nutrients.

[3]  G. Maggiore,et al.  Sarcopenia is associated with poor clinical outcomes in patients with inflammatory bowel disease: a prospective cohort study , 2022, Annals of translational medicine.

[4]  R. Shivashankar,et al.  Sarcopenia Is More Prevalent Among Inflammatory Bowel Disease Patients Undergoing Surgery and Predicts Progression to Surgery Among Medically Treated Patients. , 2022, Inflammatory bowel diseases.

[5]  J. Zhong,et al.  Prevalence of Sarcopenia and Its Effect on Postoperative Complications in Patients with Crohn's Disease , 2021, Gastroenterology research and practice.

[6]  K. Cologne,et al.  The assessment of sarcopenia using psoas muscle thickness per height is not predictive of post-operative complications in IBD , 2021, Scandinavian journal of gastroenterology.

[7]  Wei Liu,et al.  Sarcopenia assessed by computed tomography is associated with colectomy in patients with acute severe ulcerative colitis , 2021, European Journal of Clinical Nutrition.

[8]  Wei Zhou,et al.  The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients. , 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[9]  C. Chevalier,et al.  A Low Total Psoas Muscle Area Index Is a Strong Prognostic Factor in Metastatic Pancreatic Cancer , 2021, Pancreas.

[10]  P. Sahni,et al.  Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn’s disease , 2021, European Journal of Clinical Nutrition.

[11]  G. Bahat,et al.  Cut-off values of skeletal muscle index and psoas muscle index at L3 vertebra level by computerized tomography to assess low muscle mass. , 2021, Clinical nutrition.

[12]  M. Tani,et al.  Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease. , 2020, Inflammatory bowel diseases.

[13]  U. Kopylov,et al.  Low psoas muscle area is associated with postoperative complications in Crohn’s disease , 2020, International Journal of Colorectal Disease.

[14]  N. Nishida,et al.  Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib , 2020, International Journal of Clinical Oncology.

[15]  A. Koyanagi,et al.  Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review , 2020, International journal of molecular sciences.

[16]  Chen Li,et al.  Total Psoas Area Index is Valuable to Assess Sarcopenia, Sarcopenic Overweight/Obesity and Predict Outcomes in Patients Undergoing Open Pancreatoduodenectomy , 2020, Risk management and healthcare policy.

[17]  F. Frizelle,et al.  Sarcopenia, as Assessed by Psoas Cross-Sectional Area, Is Predictive of Adverse Postoperative Outcomes in Patients Undergoing Colorectal Cancer Surgery , 2020, Diseases of the colon and rectum.

[18]  M. Ribolsi,et al.  Nutritional Aspects in Inflammatory Bowel Diseases , 2020, Nutrients.

[19]  G. Piton,et al.  Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease. , 2020, Clinical nutrition.

[20]  Nayoung Kim,et al.  The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease , 2020, Intestinal research.

[21]  Yi-huan Luo,et al.  Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy , 2019, Annals of Nutrition and Metabolism.

[22]  J. Gisbert,et al.  Predictors of primary response to biologic treatment (anti-TNF, vedolizumab and ustekinumab) in patients with inflammatory bowel disease: from basic science to clinical practice. , 2019, Journal of Crohn's & colitis.

[23]  P. Hegyi,et al.  Sarcopenia as an independent predictor of the surgical outcomes of patients with inflammatory bowel disease: a meta-analysis , 2019, Surgery Today.

[24]  A. Gasbarrini,et al.  Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center , 2019, Nutrients.

[25]  C. Weiss,et al.  Skeletal Muscle Mass Index Predicts Postoperative Complications in Intestinal Surgery for Crohn's Disease. , 2019, JPEN. Journal of parenteral and enteral nutrition.

[26]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[27]  M. Kelly,et al.  Sarcopenia and Inflammatory Bowel Disease: A Systematic Review. , 2018, Inflammatory bowel diseases.

[28]  M. Gee,et al.  Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients , 2018, Journal of Crohn's & colitis.

[29]  Wendy Y Chen,et al.  Clinical implications of low skeletal muscle mass in early-stage breast and colorectal cancer , 2018, Proceedings of the Nutrition Society.

[30]  J. H. Kim,et al.  Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis , 2018, Clinical and molecular hepatology.

[31]  S. Baik,et al.  Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis , 2017, PloS one.

[32]  Dawn B. Beaulieu,et al.  Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery , 2017, Inflammatory bowel diseases.

[33]  O. Inatomi,et al.  Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn’s disease , 2017, PloS one.

[34]  Ning Li,et al.  Prevalence of Sarcopenia and Its Impact on Postoperative Outcome in Patients With Crohn’s Disease Undergoing Bowel Resection , 2017, JPEN. Journal of parenteral and enteral nutrition.

[35]  M. Talamonti,et al.  A semi-automated assessment of sarcopenia using psoas area and density predicts outcomes after pancreaticoduodenectomy for pancreatic malignancy. , 2017, Journal of Gastrointestinal Oncology.

[36]  C. Cooper,et al.  Sarcopenia in daily practice: assessment and management , 2016, BMC Geriatrics.

[37]  F. T. Veloso.  Clinical predictors of Crohn’s disease course , 2016, European journal of gastroenterology & hepatology.

[38]  H. Muss,et al.  Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. , 2016, European journal of cancer.

[39]  Tony Reiman,et al.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.